|
The pacemaker was received for analysis.Prior to the analysis of the device, the quality documents accompanying the manufacturing process for this pacemaker were reinvestigated and all production steps were performed accordingly.Particularly the final acceptance test proved the device functions to be as specified.Upon receipt, the device was interrogated properly, and the memory content of the pacemaker was inspected, showing a normal device function while implanted and in service.The battery status was greater than 55%.The pacemaker was programmed to ddd-cls mode with very sensitive sensor settings (sensor gain ¿very high¿, sensor threshold ¿very low¿).Home monitoring data were evaluated showing no anomalies, particularly, regarding the patient´s activity.The pacemaker was subjected to an electrical analysis.The ability of the device to deliver therapies was verified.The anti-bradycardia pacing pulses proved to be normal and in amplitude and frequency as programmed.In addition, the device´s accelerator was intensively tested.The heart rate adaptation was proved to be fully functional.In conclusion, the device proved to be fully functional.The analysis of the memory content showed a normal device behavior while the device was implanted and in service.There was no indication of a device malfunction.
|